EVSX holds an Environmental Compliance Approval (“ECA”) permit, issued in May 2024, allowing it to sort and process alkaline batteries in Ontario. EVSX also entered into a three-year battery supply ...
At present, olverembatinib has been approved in China for the treatment of adult patients with TKI-resistant chronic-phase chronic myeloid leukemia (CML-CP) or accelerated-phase CML (CML-AP) harboring ...